Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Leukemia

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

More Australians dying of myeloma, a blood cancer that causes bones to weaken

More Australians dying of myeloma, a blood cancer that causes bones to weaken

Each day six Australians are diagnosed with myeloma, a rare form of blood cancer that weakens bones, and about half of those people won't survive past five years.

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

Here's a roundup of top developments in the biotech space over the last 24 hours.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

FDA Grants Fast Track designation To Aptose Biosciences for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation

Aptose Biosciences Inc. (NASDAQ: APTO) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to HM43239, an oral, myeloid kinome inhibitor, for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation.

Jasper Therapeutics Presented Updated Data from Phase 1 Clinical Trial of JSP191

Jasper Therapeutics, Inc., (NASDAQ: JSPR) announced updated efficacy, safety and pharmacokinetic data from its Phase 1 clinical trial of JSP191, in older patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) undergoing allogeneic hematopoietic (blood) cell transplantation.

Gary Lineker opens up on son George's leukaemia battle and "tiny coffin" nightmare

Gary Lineker has opened up his son's harrowing battle with leukaemia as an infant - revealing that he had nightmares of carrying a "tiny little white coffin" during George's ordeal

Mustang Bio's CAR T Cell Therapy Shows Favorable Safety Profile, Response Rates In Blood Cancer Patients

Mustang Bio Inc (NASDAQ:MBIO) announced updated interim data from the ongoing Phase 1/2 trial of MB-106, a CD20-targeted, autologous CAR T cell therapy for relapsed or refractory B-cell non-Hodgkin lymphomas (B-NHLs) and chronic lymphocytic leukemia (CLL). MB-106 is being developed in a collaboration between Mustang and Fred Hutchinson Cancer Center. The data demonstrated…

inkl

Read news from The Economist, FT, and more,
with one subscription

5 Beaten-Down Biotech Stocks Cathie Wood Loves

5 Beaten-Down Biotech Stocks Cathie Wood Loves

Renowned investor Cathie Wood of ARK Invest is known for her eye for stocks with enormous upside potential. Despite recent macro headwinds, the biotech industry is expected to grow tremendously in 2022, supported by strong demand for healthcare and medical products and increasing investments in R&D. Given these factors, Wall…

1 … 4 5 6 7

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Ginkgo Bioworks Holdings Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Ulcerative Colitis

Places

366,828 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play